Pfizer's COVID-19 pill could have real impact in Canada — if we can roll it out fast enough
CBC
After Canada approved a new treatment for COVID-19, Pfizer's highly effective oral therapeutic Paxlovid, experts are hopeful the highly sought after pill can help control a devastating Omicron-driven surge — if it's rolled out fast enough.
"I think it will be an effective tool in high-risk individuals if they can get tested quick enough to be able to be in the window for therapeutic benefit," said Dr. Amesh Adalja, an infectious diseases physician and senior scholar at the Johns Hopkins Center for Health Security in Baltimore.
"If you can get it to people fast enough to keep them from needing hospitalizations, then that basically solves the major problem that we're facing."
But questions remain as to whether the provinces and territories will be able to get the drug out to sick, vulnerable Canadians within the recommended five-day window, helping to ease the pressure on hospitals until current COVID-19 levels subside.
"Obviously this is a very promising development, but there's still some work that lies ahead," Dr. Isaac Bogoch, an infectious diseases physician and member of Ontario's COVID-19 vaccine task force, told CBC News Network on Monday.
"That's fantastic we've crossed that first step. We also now, of course, need to distribute it to the provinces and to have the provinces work out how it's actually going to be administered."
WATCH | Paxlovid shows great promise despite logistical hurdles, says Dr. Isaac Bogoch:
Canada's Chief Public Health Officer Dr. Theresa Tam said Monday the antiviral treatment — made up of nirmatrelvir and ritonavir — will be in "high demand" and that officials anticipate initial supply "will not be great anywhere" as they work with provinces and territories to determine how best to roll it out.
Dr. David Naylor, who led the federal inquiry into Canada's national response to the 2003 SARS epidemic and co-chair of the federal government's COVID-19 immunity task force, said recently he's been "very frustrated" with the pace of approval.
Canada needs a Paxlovid rollout plan involving both virtual and ambulatory care, he said — one that can confirm the presence of the virus in a patient, assess the severity of their illness, prescribe the pill quickly and to ensure that available doses reach those who need it most.
"So far as I can tell, we're also dragging our feet on that front," he told CBC News. "Countless thousands of Canadians are seriously ill at home with COVID-19 and, from what I see and hear, many are feeling abandoned."
Naylor said Canada can also develop helplines for those eligible for the treatment, provide clear information on its benefits and co-ordinate outpatient care to support patients at home — instead of assuming their situation is "irrelevant" unless they're hospitalized.
After several months of clinical trials, Pfizer had reported in November that Paxlovid reduced the risk of hospitalization or death by an impressive 89 per cent compared with a placebo in non-hospitalized high-risk adults with COVID-19.
Canada has pre-purchased one million doses of the drug, with the first batch of 30,000 to be distributed on a per-capita basis and more arriving in the coming days. It will no doubt spark a rapid push to disperse the treatment to those at highest risk as soon as possible.
Run 3 Space | Play Space Running Game
Traffic Jam 3D | Online Racing Game
Duck Hunt | Play Old Classic Game
The 32-year-old man who died at the Windsor jail last month is being remembered as a great man who always wanted to help those who needed it.
In one week, Patrick Cully will find out whether his five-year-old daughter Scarlet will be able to continue the life-changing therapy she's relied on for more than a year — or if long waitlists and a lack of funding will halt her progress.
As Conestoga College faces layoffs and program suspensions, the union leaders representing its employees say the toll on the workers is mounting.
Hoping to drive more people downtown and breathe more life into the area, the City of Summerside is now going over a number of recommendations on how to revitalize its downtown and waterfront.
Yukon First Nations are calling on the territorial government to repeal amendments it made in May to mining regulations.
Wanda Resmer says she didn't see the news coming.
Residents along the Toronto West Railpath are frustrated with what they say is a lack of transparency from Metrolinx on end dates for nearby construction projects, their city councillor says.
As officials try to make sense of an alleged multi-year fraud engineered so several people could personally profit from money meant to be spent on keeping London's hospitals running, CBC News dug into the people accused in the scheme.
U.S. President Donald Trump is threatening to slap a 35 per cent tariff on all Canadian goods as the two countries have been engaged in negotiations to reach some sort of trade agreement.
Nova Scotia's minister of education and early childhood development says the province will need more "help" from Ottawa to achieve $10-a-day child care by March 2026.
For years now, business has slowed down between April and November at Doiron Sports Excellence on the west side of Saint John because of the rehabilitation work on Harbour Bridge.
A wildfire has entered the northern Saskatchewan community of Beauval, the village's mayor says.
Hugs, tears, and signs with slogans in protest of domestic abuse filled the steps of the Kelowna Law Courts building on Thursday, ahead of James Plover's first appearance in court on a charge of second-degree murder.